Cholangiokines: undervalued modulators in the hepatic microenvironment
Open accessThe DOI matches its Crossref record; 226 of the 229 references it cites were found in a registry or an index.
Abstract
The biliary epithelial cells, also known as cholangiocytes, line the intra- and extrahepatic bile ducts, forming a barrier between intra- and extra-ductal environments. Cholangiocytes are mostly known to modulate bile composition and transportation. In hepatobiliary diseases, bile duct injury leads to drastic alterations in cholangiocyte phenotypes and their release of soluble mediators, which can vary depending on the original insult and cellular states (quiescence, senescence, or proliferation). The cholangiocyte-secreted cytokines (also termed cholangiokines) drive ductular cell proliferation, portal inflammation and fibrosis, and carcinogenesis. Hence, despite the previous consensus that cholangiocytes are bystanders in liver diseases, their diverse secretome plays critical roles in modulating the intrahepatic microenvironment. This review summarizes recent insights into the cholangiokines under both physiological and pathological conditions, especially as they occur during liver injury-regeneration, inflammation, fibrosis and malignant transformation processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, their microanatomic niche predisposes BECs to interact with many other cell types, including immune cells, and renders the periductular area a common site of inflammation [155–157].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [156]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Biliary epithelial cells (BECs) and their derivatives, often referred to as ductular cells in liver diseases, play a key role in many liver diseases, as the transport of bile to the intestine is a central liver function that needs to be preserved to avoid toxic effects on the liver.”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [156]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Hallmarks of Cellular Senescence
Hernandez-Segura, A., Nehme, J., & Demaria, M. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.02.001 · Cited by 2,605
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986
IL‐6: Regulator of Treg/Th17 balance
Kimura, A., & Kishimoto, T. (2010) · European Journal of Immunology · doi:10.1002/eji.201040391 · Cited by 1,595
Liver regeneration: from myth to mechanism
Taub, R. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1489 · Cited by 1,567
Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations
MacParland, S. A., Liu, J. C., Ma, X.-Z., Innes, B. T., Bartczak, A. M., Gage, B. K., Manuel, J., Khuu, N., Echeverri, J., Linares, I., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06318-7 · Cited by 1,552
Imai, T., Hieshima, K., Haskell, C., Baba, M., Nagira, M., Nishimura, M., Kakizaki, M., Takagi, S., Nomiyama, H., Schall, T. J., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80438-9 · Cited by 1,445
Liver Macrophages in Tissue Homeostasis and Disease
Krenkel, O., & Tacke, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.11 · Cited by 1,424 · cited 1×
“Although hepatocytes and Kupffer cells are generally responsible for the clearance of bacterial products in the liver (51, 52), cholangiocytes can also play auxiliary roles in this process, especially regarding the response to intraductal stimuli.”
BackgroundSelf-citationMichalopoulos, G. K. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21172 · Cited by 1,384
Immunology in the liver — from homeostasis to disease
Heymann, F., & Tacke, F. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.200 · Cited by 1,180 · cited 1×
“Studies have showed that higher levels of interleukin-8 (IL-8), a potent chemoattractant for neutrophils, were detected in the bile of PSC patients as compared to non-PSC patients (28, 29), which suggests that bile duct injury induces the secretion of inflammatory cytokines into the bile (30).”
ResultSelf-citationSenescence-associated reprogramming promotes cancer stemness
Milanovic, M., Fan, D. N. Y., Belenki, D., Däbritz, J. H. M., Zhao, Z., Yu, Y., Dörr, J. R., Dimitrova, L., Lenze, D., Monteiro Barbosa, I. A., et al. (2018) · Nature · doi:10.1038/nature25167 · Cited by 1,131
Liver regeneration: biological and pathological mechanisms and implications
Michalopoulos, G. K., & Bhushan, B. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0342-4 · Cited by 998
IL-6 pathway in the liver: From physiopathology to therapy
Schmidt-Arras, D., & Rose-John, S. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.004 · Cited by 978
Lin, A. W., Barradas, M., Stone, J. C., van Aelst, L., Serrano, M., & Lowe, S. W. (1998) · Genes & Development · doi:10.1101/gad.12.19.3008 · Cited by 945
TNF-α in promotion and progression of cancer
Balkwill, F. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9005-3 · Cited by 915
Gut-liver axis: Pathophysiological concepts and clinical implications
Tilg, H., Adolph, T. E., & Trauner, M. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.09.017 · Cited by 843
Carey, E. J., Ali, A. H., & Lindor, K. D. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00154-3 · Cited by 735
Liver — guardian, modifier and target of sepsis
Strnad, P., Tacke, F., Koch, A., & Trautwein, C. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.168 · Cited by 692 · cited 1×
“Similar cholangiopathies with vanishing bile ducts, biliary strictures and protein casts also occur after ischemic insults, including ischemic-type biliary lesions (ITBL) after liver transplantation, secondary sclerosing cholangitis of critically ill patients (SC-CIP) after acute respiratory distress syndrome, COVID-1…”
BackgroundSelf-citationAlmazroo, O. A., Miah, M. K., & Venkataramanan, R. (2017) · Clinics in Liver Disease · doi:10.1016/j.cld.2016.08.001 · Cited by 681 · cited 1×
“Interestingly, cholangiocytes are implicated in drug metabolism as they were shown to express cytochrome P450 (CYP450) superfamily members (69, 70) .”
BackgroundEggert, T., Wolter, K., Ji, J., Ma, C., Yevsa, T., Klotz, S., Medina-Echeverz, J., Longerich, T., Forgues, M., Reisinger, F., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.09.003 · Cited by 609
The Roles of CD8+ T Cell Subsets in Antitumor Immunity
St. Paul, M., & Ohashi, P. S. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.06.003 · Cited by 609
Zhang, M., Yang, H., Wan, L., Wang, Z., Wang, H., Ge, C., Liu, Y., Hao, Y., Zhang, D., Shi, G., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.05.039 · Cited by 605
Human gut bacteria produce ΤΗ17-modulating bile acid metabolites
Paik, D., Yao, L., Zhang, Y., Bae, S., D’Agostino, G. D., Zhang, M., Kim, E., Franzosa, E. A., Avila-Pacheco, J., Bisanz, J. E., et al. (2022) · Nature · doi:10.1038/s41586-022-04480-z · Cited by 594
Emerging therapeutic opportunities for integrin inhibitors
Slack, R. J., Macdonald, S. J. F., Roper, J. A., Jenkins, R. G., & Hatley, R. J. D. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00284-4 · Cited by 540
Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration
Raven, A., Lu, W.-Y., Man, T. Y., Ferreira-Gonzalez, S., O’Duibhir, E., Dwyer, B. J., Thomson, J. P., Meehan, R. R., Bogorad, R., Koteliansky, V., et al. (2017) · Nature · doi:10.1038/nature23015 · Cited by 533 · cited 1×
“Even though the replication rate is limited in the quiescent state, cholangiocytes are able to re-enter cell-cycle and proliferate upon various exogenous or endogenous insults (97), and even compensate for the proliferation-incapable hepatocytes to regenerate liver parenchyma (98).”
BackgroundBanales, J. M., Huebert, R. C., Karlsen, T., Strazzabosco, M., LaRusso, N. F., & Gores, G. J. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0125-y · Cited by 517 · cited 1×
“Cholangiocytes, also known as biliary epithelial cells (BECs), are specialized epithelial cells forming the biliary epithelium and lining the bile ducts (1).”
BackgroundDuctular reaction in liver diseases: pathological mechanisms and translational significances
Sato, K., Marzioni, M., Meng, F., Francis, H., Glaser, S., & Alpini, G. (2019) · Hepatology · doi:10.1002/hep.30150 · Cited by 423
Mehta, A. K., Gracias, D. T., & Croft, M. (2018) · Cytokine · doi:10.1016/j.cyto.2016.08.003 · Cited by 404
Fuchs, B. C., Hoshida, Y., Fujii, T., Wei, L., Yamada, S., Lauwers, G. Y., McGinn, C. M., DePeralta, D. K., Chen, X., Kuroda, T., et al. (2014) · Hepatology · doi:10.1002/hep.26898 · Cited by 351
Kumar, S., Duan, Q., Wu, R., Harris, E. N., & Su, Q. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113869 · Cited by 351 · cited 1×
“The activation of these specific intracellular pathways leads to a nuclear factor kappa-B (NF-kB)-dependent secretion of proinflammatory cytokines/chemokines (59).”
BackgroundImmunoregulation by members of the TGFβ superfamily
Chen, W., & ten Dijke, P. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.112 · Cited by 347
Liver Macrophages: Old Dogmas and New Insights
Guillot, A., & Tacke, F. (2019) · Hepatology Communications · doi:10.1002/hep4.1356 · Cited by 335
Self-citationAlpini, G., Lenzi, R., Sarkozi, L., & Tavoloni, N. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113355 · Cited by 332 · cited 2×
“Other than inducing biliary bicarbonate secretion by binding with its basolateral receptor (SR) (7, 37, 38), the Sct/SR axis plays a key role in the modulation of biliary proliferation and hepatic fibrosis by influencing the BEC secretome (35, 36, 39).”
BackgroundIntrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances
Sirica, A. E., Gores, G. J., Groopman, J. D., Selaru, F. M., Strazzabosco, M., Wei Wang, X., & Zhu, A. X. (2019) · Hepatology · doi:10.1002/hep.30289 · Cited by 315
Single-cell Stereo-seq reveals induced progenitor cells involved in axolotl brain regeneration
Wei, X., Fu, S., Li, H., Liu, Y., Wang, S., Feng, W., Yang, Y., Liu, X., Zeng, Y.-Y., Cheng, M., et al. (2022) · Science · doi:10.1126/science.abp9444 · Cited by 311
Chandra, T., Kirschner, K., Thuret, J.-Y., Pope, B. D., Ryba, T., Newman, S., Ahmed, K., Samarajiwa, S. A., Salama, R., Carroll, T., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.06.010 · Cited by 308
Liver regeneration and inflammation: from fundamental science to clinical applications
Campana, L., Esser, H., Huch, M., & Forbes, S. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00373-7 · Cited by 307
Tim-3 fosters HCC development by enhancing TGF-β-mediated alternative activation of macrophages
Yan, W., Liu, X., Ma, H., Zhang, H., Song, X., Gao, L., Liang, X., & Ma, C. (2015) · Gut · doi:10.1136/gutjnl-2014-307671 · Cited by 306
Milani, S., Herbst, H., Schuppan, D., Stein, H., & Surrenti, C. (1991) · PubMed Central · Cited by 298
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
Brevini, T., Maes, M., Webb, G. J., John, B. V., Fuchs, C. D., Buescher, G., Wang, L., Griffiths, C., Brown, M. L., Scott, W. E., et al. (2023) · Nature · doi:10.1038/s41586-022-05594-0 · Cited by 293 · cited 1×
“Additionally, SARS-CoV-2 can infect cholangiocytes via the angiotensin-converting enzyme 2 (ACE2), which can be reduced by ursodeoxycholic acid while being induced by farnesoid X receptor (FXR) signaling in cholangiocytes (65).”
BackgroundMarra, F., DeFranco, R., Grappone, C., Milani, S., Pastacaldi, S., Pinzani, M., Romanelli, R. G., Laffi, G., & Geñtilini, P. (1998) · Europe PMC (PubMed Central) · Cited by 289
Schaap, F. G., van der Gaag, N. A., Gouma, D. J., & Jansen, P. L. M. (2009) · Hepatology · doi:10.1002/hep.22771 · Cited by 284
Ductular reactions in human liver: Diversity at the interface
Gouw, A. S. H., Clouston, A. D., & Theise, N. D. (2011) · Hepatology · doi:10.1002/hep.24613 · Cited by 275
The Pathophysiology of Biliary Epithelia
Alpini, G., Alvaro, D., Marzioni, M., LeSage, G., & LaRusso, N. (2020) · CRC Press eBooks · doi:10.1201/9780367813888 · Cited by 263
Immunomodulatory TGF-β Signaling in Hepatocellular Carcinoma
Chen, J., Gingold, J. A., & Su, X. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.06.007 · Cited by 260
Tabibian, J. H., O'Hara, S. P., Splinter, P. L., Trussoni, C. E., & LaRusso, N. F. (2014) · Hepatology · doi:10.1002/hep.26993 · Cited by 241
Defense system in the biliary tract against bacterial infection
Sung, J. Y., Costerton, J. W., & Shaffer, E. A. (1992) · Digestive Diseases and Sciences · doi:10.1007/bf01296423 · Cited by 236
Morphological, molecular, and functional heterogeneity of cholangiocytes from normal rat liver
Alpini, G., Roberts, S., Kuntz, S., Ueno, Y., Gubba, S., Podila, P., LeSage, G., & LaRusso, N. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8613073 · Cited by 236 · cited 1×
“Other than inducing biliary bicarbonate secretion by binding with its basolateral receptor (SR) (7, 37, 38), the Sct/SR axis plays a key role in the modulation of biliary proliferation and hepatic fibrosis by influencing the BEC secretome (35, 36, 39).”
BackgroundIL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma
Xu, J., Lin, H., Wu, G., Zhu, M., & Li, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.760971 · Cited by 228
Isomoto, H., Kobayashi, S., Werneburg, N. W., Bronk, S. F., Guicciardi, M. E., Frank, D. A., & Gores, G. J. (2005) · Hepatology · doi:10.1002/hep.20966 · Cited by 227
Kinnman, N., Francoz, C., Barbu, V., Wendum, D., Rey, C., Hultcrantz, R., Poupon, R., & Housset, C. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000054178.01162.e4 · Cited by 222 · cited 16×
“, IL-6, TGF-b1/2, CCL-2 and PDGF-B) (76, 94, 95).”
BackgroundInfluentialLiu, R., Li, X., Zhu, W., Wang, Y., Zhao, D., Wang, X., Gurley, E. C., Liang, G., Chen, W., Lai, G., et al. (2019) · Hepatology · doi:10.1002/hep.30662 · Cited by 221
D'Aldebert, E., Biyeyeme Bi Mve, M., Mergey, M., Wendum, D., Firrincieli, D., Coilly, A., Fouassier, L., Corpechot, C., Poupon, R., Housset, C., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.040 · Cited by 219
Gong, A.-Y., Zhou, R., Hu, G., Li, X., Splinter, P. L., O'Hara, S. P., LaRusso, N. F., Soukup, G. A., Dong, H., & Chen, X.-M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1325 · Cited by 217
Lorent, K., Yeo, S.-Y., Oda, T., Chandrasekharappa, S., Chitnis, A., Matthews, R. P., & Pack, M. (2004) · Development · doi:10.1242/dev.01411 · Cited by 216
Jeffery, H. C., van Wilgenburg, B., Kurioka, A., Parekh, K., Stirling, K., Roberts, S., Dutton, E. E., Hunter, S., Geh, D., Braitch, M. K., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.12.017 · Cited by 212
TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro
Reich, M., Deutschmann, K., Sommerfeld, A., Klindt, C., Kluge, S., Kubitz, R., Ullmer, C., Knoefel, W. T., Herebian, D., Mayatepek, E., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309458 · Cited by 210 · cited 1×
“The beneficial secretion of bicarbonate and chloride was known attributing to the TGR5-mediated cholangiocyte activation (48).”
BackgroundLazaridis, K. N., & LaRusso, N. F. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.03.017 · Cited by 210
Combined hepatocellular-cholangiocarcinoma: An update
Beaufrère, A., Calderaro, J., & Paradis, V. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.01.035 · Cited by 203
The gut-liver axis in sepsis: interaction mechanisms and therapeutic potential
Zhang, X., Liu, H., Hashimoto, K., Yuan, S., & Zhang, J. (2022) · Critical Care · doi:10.1186/s13054-022-04090-1 · Cited by 200
Self-citationPost–COVID-19 Cholangiopathy: A Novel Entity
Roth, N. C., Kim, A., Vitkovski, T., Xia, J., Ramirez, G., Bernstein, D., & Crawford, J. M. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001154 · Cited by 198
Yuan, D., Huang, S., Berger, E., Liu, L., Gross, N., Heinzmann, F., Ringelhan, M., Connor, T. O., Stadler, M., Meister, M., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.05.006 · Cited by 197
The biliary epithelium gives rise to liver progenitor cells
Rodrigo-Torres, D., Affò, S., Coll, M., Morales-Ibanez, O., Millán, C., Blaya, D., Alvarez-Guaita, A., Rentero, C., José Lozano, J., Maestro, M. A., et al. (2014) · Hepatology · doi:10.1002/hep.27078 · Cited by 189
The tumour microenvironment and immune milieu of cholangiocarcinoma
Fabris, L., Perugorria, M. J., Mertens, J., Björkström, N. K., Cramer, T., Lleo, A., Solinas, A., Sänger, H., Lukacs‐Kornek, V., Moncsek, A., et al. (2019) · Liver International · doi:10.1111/liv.14098 · Cited by 187
Popov, Y., Patsenker, E., Stickel, F., Zaks, J., Bhaskar, K. R., Niedobitek, G., Kolb, A., Friess, H., & Schuppan, D. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.11.021 · Cited by 185
Uriarte, I., Fernandez-Barrena, M. G., Monte, M. J., Latasa, M. U., Chang, H. C. Y., Carotti, S., Vespasiani-Gentilucci, U., Morini, S., Vicente, E., Concepcion, A. R., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-302945 · Cited by 183
Harada, K., Shimoda, S., Sato, Y., Isse, K., Ikeda, H., & Nakanuma, Y. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.03947.x · Cited by 180 · cited 16×
“Last but not least, unstimulated primary human intrahepatic BECs secrete a panel of cytokines/chemokines in vitro, including IL-8, IL-4 and MCP-1 (102, 106), as well as insulin-like growth factor-1 (IGF-1) from healthy cholangiocytes (123).”
BackgroundInfluentialPathophysiological Role of Osteopontin in Hepatic Inflammation, Toxicity, and Cancer
Ramaiah, S. K., & Rittling, S. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfm246 · Cited by 180 · cited 1×
“It has been reported that BDL-induced bile duct obstruction in mice triggers cholangiocytes to secrete osteopontin (OPN) (45, 46).”
BackgroundMatsumoto, K., Fujii, H., Michalopoulos, G., Fung, J. J., & Demetris, A. J. (1994) · Hepatology · doi:10.1002/hep.1840200217 · Cited by 165
Corylin protects LPS-induced sepsis and attenuates LPS-induced inflammatory response
Hung, Y., Fang, S., Wang, S., Cheng, W., Liu, P., Su, C., Chen, C.-S., Huang, M., Hua, K., Shen, K., et al. (2017) · Scientific Reports · doi:10.1038/srep46299 · Cited by 165 · cited 1×
“With the assistance of NO, IL-6 is involved in the LPS-induced sepsis-related systemic inflammatory response and is one of the most powerful mitogens for cholangiocytes (87, 88).”
BackgroundLanzoni, G., Cardinale, V., & Carpino, G. (2016) · Hepatology · doi:10.1002/hep.28326 · Cited by 163
The dynamic biliary epithelia: Molecules, pathways, and disease
O’Hara, S. P., Tabibian, J. H., Splinter, P. L., & LaRusso, N. F. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.10.011 · Cited by 162
Rai, T. S., Cole, J. J., Nelson, D. M., Dikovskaya, D., Faller, W. J., Vizioli, M. G., Hewitt, R. N., Anannya, O., McBryan, T., Manoharan, I., et al. (2014) · Genes & Development · doi:10.1101/gad.247528.114 · Cited by 162
Paracrine cellular senescence exacerbates biliary injury and impairs regeneration
Ferreira-Gonzalez, S., Lu, W.-Y., Raven, A., Dwyer, B., Man, T. Y., O’Duibhir, E., Lewis, P. J. S., Campana, L., Kendall, T. J., Bird, T. G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03299-5 · Cited by 161
Integrin αvβ6: Structure, function and role in health and disease
Koivisto, L., Bi, J., Häkkinen, L., & Larjava, H. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.04.013 · Cited by 160
Kullak-Ublick, G. A., Beuers, U., & Paumgartner, G. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80411-0 · Cited by 160 · cited 1×
“Gradually concentrated and thickened bile exerts detrimental effects on the gut-liver axis, thus referred to as ‘toxic bile’ (27).”
BackgroundGoydos, J. S., Brumfield, A., Frezza, E., Booth, A., Lotze, M., & Carty, S. (1998) · Annals of Surgery · doi:10.1097/00000658-199803000-00012 · Cited by 160
Alvaro, D., Barbaro, B., Franchitto, A., Onori, P., Glaser, S. S., Alpini, G., Francis, H., Marucci, L., Sterpetti, P., Ginanni-Corradini, S., et al. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050464 · Cited by 159
Isse, K., Harada, K., Zen, Y., Kamihira, T., Shimoda, S., Harada, M., & Nakanuma, Y. (2005) · Hepatology · doi:10.1002/hep.20582 · Cited by 158
The pathobiology of biliary epithelia
Alpini, G., McGill, J. M., & LaRusso, N. F. (2002) · Hepatology · doi:10.1053/jhep.2002.33541 · Cited by 157 · cited 1×
“Cholangiocytes represent a heterogeneous population in terms of morphological characteristics, classically described as small or large cholangiocytes (5).”
BackgroundSedlaczek, N., Jia, J.-D., Bauer, M., Herbst, H., Ruehl, M., Hahn, E. G., & Schuppan, D. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64074-6 · Cited by 152
Spirlì, C., Fabris, L., Duner, E., Fiorotto, R., Ballardini, G., Roskams, T., LaRusso, N. F., Sonzogni, A., Okolicsànyi, L., & Strazzabosco, M. (2003) · Gastroenterology · doi:10.1053/gast.2003.50100 · Cited by 148
Upregulation of secretin receptor gene expression in rat cholangiocytes after bile duct ligation
Alpini, G., Ulrich, C. D., Phillips, J. O., Pham, L. D., Miller, L. J., & LaRusso, N. F. (1994) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1994.266.5.g922 · Cited by 147 · cited 5×
“It has been reported that BDL-induced bile duct obstruction in mice triggers cholangiocytes to secrete osteopontin (OPN) (45, 46).”
BackgroundInfluentialSasatomi, K., Noguchi, K., Sakisaka, S., Sata, M., & Tanikawa, K. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80058-5 · Cited by 144
Kirillova, I., Chaisson, M. L., & Fausto, N. (1999) · PubMed · Cited by 143
Zweers, S. J. L. B., Booij, K. A. C., Komuta, M., Roskams, T., Gouma, D. J., Jansen, P. L. M., & Schaap, F. G. (2012) · Hepatology · doi:10.1002/hep.24702 · Cited by 141
Yokoyama, T., Komori, A., Nakamura, M., Takii, Y., Kamihira, T., Shimoda, S., Mori, T., Fujiwara, S., Koyabu, M., Taniguchi, K., et al. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01254.x · Cited by 136 · cited 11×
“CCL-2, IL-8 and IL-4 Primary iBECs from the non-cancerous liver specimens of one iCCA patient (102)”
BackgroundInfluentialMoncsek, A., Al‐Suraih, M. S., Trussoni, C. E., O'Hara, S. P., Splinter, P. L., Zuber, C., Patsenker, E., Valli, P. V., Fingas, C. D., Weber, A., et al. (2018) · Hepatology · doi:10.1002/hep.29464 · Cited by 136
Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology
Pinto, C., Giordano, D. M., Maroni, L., & Marzioni, M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.024 · Cited by 136 · cited 2×
“In response to a variety of insults, including infections, cholestasis and ischemia, quiescent cholangiocytes can be activated (97), and acquire a hyperproliferative and neuroendocrine-like phenotype with pro-fibrotic and pro-inflammatory secretome (57).”
BackgroundRussell, J. O., Lu, W., Okabe, H., Abrams, M., Oertel, M., Poddar, M., Singh, S., Forbes, S. J., & Monga, S. P. (2019) · Hepatology · doi:10.1002/hep.30270 · Cited by 136
Grappone, C., Pinzani, M., Parola, M., Pellegrini, G., Caligiuri, A., DeFranco, R., Marra, F., Herbst, H., Alpini, G., & Milani, S. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80169-x · Cited by 133
Bile formation and secretion: An update
Boyer, J. L., & Soroka, C. J. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.02.011 · Cited by 133
Yokomuro, S., Tsuji, H., Lunz, J. G., Sakamoto, T., Ezure, T., Murase, N., & Demetris, A. J. (2000) · Hepatology · doi:10.1053/jhep.2000.8535 · Cited by 132
Clapéron, A., Mergey, M., Ho-Bouldoires, T. H. N., Vignjevic, D. M., Wendum, D., Chrétien, Y., Merabtene, F., Frazao, A., Paradis, V., Housset, C., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.03.033 · Cited by 132
Kruglov, E. A., Nathanson, R. A., Nguyen, T., & Dranoff, J. A. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00308.2005 · Cited by 132 · cited 17×
“, IL-6, TGF-b1/2, CCL-2 and PDGF-B) (76, 94, 95).”
BackgroundInfluentialYasoshima, M., Kono, N., Sugawara, H., Katayanagi, K., Harada, K., & Nakanuma, Y. (1998) · PubMed · Cited by 130
Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications
Faruqui, S., Okoli, F. C., Olsen, S. K., Feldman, D. M., Kalia, H. S., Park, J. S., Stanca, C. M., Diaz, V. F., Yuan, S., Dagher, N. N., et al. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001264 · Cited by 127
Poch, T., Krause, J., Casar, C., Liwinski, T., Glau, L., Kaufmann, M., Ahrenstorf, A. E., Hess, L. U., Ziegler, A. E., Martrus, G., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.03.016 · Cited by 123
Peng, Z., Ikenaga, N., Liu, S. B., Sverdlov, D. Y., Vaid, K. A., Dixit, R., Weinreb, P. H., Violette, S., Sheppard, D., Schuppan, D., et al. (2016) · Hepatology · doi:10.1002/hep.28274 · Cited by 118
Guillot, A., Winkler, M., Silva Afonso, M., Aggarwal, A., Lopez, D., Berger, H., Kohlhepp, M. S., Liu, H., Özdirik, B., Eschrich, J., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000270 · Cited by 116
Self-citationSasaki, M., Miyakoshi, M., Sato, Y., & Nakanuma, Y. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.008 · Cited by 115
Functional Heterogeneity of Cholangiocytes
Marzioni, M., Glaser, S. S., Francis, H., Phinizy, J. L., LeSage, G., & Alpini, G. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-34501 · Cited by 114
Ye, F., Shen, H., Li, Z., Meng, F., Li, L., Yang, J., Chen, Y., Bo, X., Zhang, X., & Ni, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150519 · Cited by 113
Clapéron, A., Mergey, M., Aoudjehane, L., Ho-Bouldoires, T. H. N., Wendum, D., Prignon, A., Merabtene, F., Firrincieli, D., Desbois-Mouthon, C., Scatton, O., et al. (2013) · Hepatology · doi:10.1002/hep.26585 · Cited by 111
Gaudio, E., Onori, P., Pannarale, L., & Alvaro, D. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70081-1 · Cited by 111
Locatelli, L., Cadamuro, M., Spirlì, C., Fiorotto, R., Lecchi, S., Morell, C. M., Popov, Y., Scirpo, R., De Matteis, M., Amenduni, M., et al. (2016) · Hepatology · doi:10.1002/hep.28382 · Cited by 108
Thepmalee, C., Panya, A., Junking, M., Chieochansin, T., & Yenchitsomanus, P. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1431598 · Cited by 108
Gigliozzi, A., Alpini, G. D., Svegliati‐Baroni, G., Marucci, L., Metalli, V. D., Glaser, S. S., Francis, H., Mancino, M. G., Ueno, Y., Barbaro, B., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.06.023 · Cited by 106
Sheng, J., Zhang, J., Wang, L., Tano, V., Tang, J., Wang, X., Wu, J., Song, J., Zhao, Y., Rong, J., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-324339 · Cited by 106
Advances in cholangiocyte immunobiology
Syal, G., Fausther, M., & Dranoff, J. A. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00227.2012 · Cited by 105 · cited 1×
“Fundamentally, cholangiocytes express the Toll-like receptor (TLR) family proteins, which are well-known as mediators in innate immune responses (57, 58).”
BackgroundTabibian, J. H., Trussoni, C. E., O'Hara, S. P., Splinter, P. L., Heimbach, J. K., & LaRusso, N. F. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.94 · Cited by 104
The biliary epithelium presents antigens to and activates natural killer T cells
Schrumpf, E., Tan, C., Karlsen, T. H., Sponheim, J., Björkström, N. K., Sundnes, O., Alfsnes, K., Kaser, A., Jefferson, D. M., Ueno, Y., et al. (2015) · Hepatology · doi:10.1002/hep.27840 · Cited by 104
Liu, Z., Sakamoto, T., Ezure, T., Yokomuro, S., Murase, N., Michalopoulos, G., & Demetris, A. J. (1998) · Hepatology · doi:10.1002/hep.510280514 · Cited by 103
Yoon, J., Canbay, A. E., Werneburg, N. W., Lee, S. P., & Gores, G. J. (2004) · Hepatology · doi:10.1002/hep.20125 · Cited by 100
Ning, J., Ye, Y., Bu, D., Zhao, G., Song, T., Liu, P., Yu, W., Wang, H., Li, H., Ren, X., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.02.016 · Cited by 99
Etienne-Mesmin, L., Vijay-Kumar, M., Gewirtz, A. T., & Chassaing, B. (2016) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2016.04.007 · Cited by 98
Glaser, S. S., Meng, F., Han, Y., Onori, P., Chow, B., Francis, H., Venter, J. K., McDaniel, K. M., Marzioni, M., Invernizzi, P., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.030 · Cited by 98
Harada, K., Ohba, K., Ozaki, S., Isse, K., Hirayama, T., Wada, A., & Nakanuma, Y. (2004) · Hepatology · doi:10.1002/hep.1840400423 · Cited by 97
Wu, N., Meng, F., Invernizzi, P., Bernuzzi, F., Venter, J., Standeford, H., Onori, P., Marzioni, M., Alvaro, D., Franchitto, A., et al. (2016) · Hepatology · doi:10.1002/hep.28622 · Cited by 97
Visentin, M., Lenggenhager, D. M., Gai, Z., & Kullak-Ublick, G. A. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.08.033 · Cited by 97 · cited 1×
“Certain medications, including carbamazepine and amoxicillin/clavulanic acid, have been shown to cause biliary damage (67).”
BackgroundRole of Osteopontin in Liver Diseases
Wen, Y., Jeong, S., Xia, Q., & Kong, X. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.16445 · Cited by 95 · cited 1×
“It has been reported that BDL-induced bile duct obstruction in mice triggers cholangiocytes to secrete osteopontin (OPN) (45, 46).”
BackgroundLamireau, T., Zoltowska, M., Levy, E. H., Yousef, I. M., Rosenbaum, J., Tuchweber, B., & Desmoulière, A. (2003) · Life Sciences · doi:10.1016/s0024-3205(02)02408-6 · Cited by 94
Kunzmann, L. K., Schoknecht, T., Poch, T., Henze, L., Stein, S., Kriz, M., Grewe, I., Preti, M., Hartl, J., Pannicke, N., et al. (2020) · Hepatology · doi:10.1002/hep.31140 · Cited by 93
Mancino, A., Mancino, M. G., Glaser, S. S., Alpini, G. D., Bolognese, A., Izzo, L., Francis, H., Onori, P., Franchitto, A., Corradini, S. G., et al. (2008) · Digestive and Liver Disease · doi:10.1016/j.dld.2008.02.015 · Cited by 92
Emerging concepts in biliary repair and fibrosis
Fabris, L., Spirli, C., Cadamuro, M., Fiorotto, R., & Strazzabosco, M. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00452.2016 · Cited by 92
Regulation of Cellular Senescence by miR-34a in Alcoholic Liver Injury
Wan, Y., McDaniel, K. M., Wu, N., Ramos‐Lorenzo, S., Glaser, T., Venter, J. K., Francis, H., Kennedy, L. L., Sato, K., Zhou, T., et al. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.08.027 · Cited by 91
Pathogenesis of biliary fibrosis
Pinzani, M., & Luong, T. V. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.026 · Cited by 90
Glaser, S., Lam, I. P., Franchitto, A., Gaudio, E., Onori, P., Chow, B. K., Wise, C., Kopriva, S., Venter, J., White, M., et al. (2010) · Hepatology · doi:10.1002/hep.23657 · Cited by 89
Morland, C. M., Fear, J., McNab, G. L., Joplin, R., & Adams, D. (1997) · PubMed · Cited by 87
New insights on the role of vascular endothelial growth factor in biliary pathophysiology
Mariotti, V., Fiorotto, R., Cadamuro, M., Fabris, L., & Strazzabosco, M. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100251 · Cited by 87 · cited 2×
“Besides, BECs exposed to IFN-g exhibit a phenotypic flip between the acute and chronic inflammatory processes in terms of their release of inflammatory components (84).”
BackgroundPathogen infections and primary biliary cholangitis
Tanaka, A., Leung, P. S. C., & Gershwin, M. E. (2018) · Clinical and Experimental Immunology · doi:10.1111/cei.13198 · Cited by 86 · cited 1×
“coli infection is known as a key factor in breaking immunological tolerance against the mitochondria, resulting in the production of PBC-specific autoantibodies (termed anti-mitochondrial autoantibodies) (62).”
BackgroundGuillot, A., Guerri, L., Feng, D., Kim, S.-J., Ahmed, Y. A., Paloczi, J., He, Y., Schuebel, K., Dai, S., Liu, F., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci132305 · Cited by 86
Self-citationMueller, T., Beutler, C., Picó, A. H., Shibolet, O., Pratt, D. S., Pascher, A., Neuhaus, P., Wiedenmann, B., Berg, T., & Podolsky, D. K. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02635.x · Cited by 85 · cited 7×
“For example, IL-8 and TNF-a levels are substantially elevated in cholangiocytes from individuals with advanced PSC compared to those at the early disease stage (107).”
BackgroundInfluentialAlvaro, D., Metalli, V. D., Alpini, G. D., Onori, P., Franchitto, A., Barbaro, B., Glaser, S. S., Francis, H., Cantàfora, A., Blotta, I., et al. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.04.011 · Cited by 85
Liver Injury and the Macrophage Issue: Molecular and Mechanistic Facts and Their Clinical Relevance
Roohani, S., & Tacke, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147249 · Cited by 85
Self-citationNinlawan, K., O'Hara, S. P., Splinter, P. L., Yongvanit, P., Kaewkes, S., Surapaitoon, A., LaRusso, N. F., & Sripa, B. (2010) · Parasitology International · doi:10.1016/j.parint.2010.09.008 · Cited by 84
Vesterhus, M. N., Holm, A., Hov, J. R., Nygård, S., Schrumpf, E., Melum, E., Thorbjørnsen, L. W., Paulsen, V., Lundin, K. E. A., Dale, I., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.019 · Cited by 84
Molecular mechanism of cholangiocarcinoma carcinogenesis
Maemura, K., Natsugoe, S., & Takao, S. (2014) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.126 · Cited by 82
Pi, L., Robinson, P. M., Jorgensen, M., Oh, S., Brown, A. R., Weinreb, P. H., Trinh, T. L., Yianni, P., Liu, C., Leask, A., et al. (2015) · Hepatology · doi:10.1002/hep.27425 · Cited by 80
Dong, Z., Sun, D., Yang, Y., Zhou, W. J., Wu, R. T., Wang, X., Shi, K., Yan, Y., Yan, L., Yao, C., et al. (2020) · Hepatology · doi:10.1002/hep.31076 · Cited by 80
Mancinelli, R., Franchitto, A., Gaudio, E., Onori, P., Glaser, S. S., Francis, H., Venter, J. K., DeMorrow, S., Carpino, G., Kopriva, S. E., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090677 · Cited by 77
Shinichiro, H., Masaru, H., Hironori, K., Takumi, K., Eitaro, T., Ryukichi, K., Takato, U., Yoshiyuki, U., Motoyasu, I., Shotaro, S., et al. (2003) · Liver International · doi:10.1034/j.1600-0676.2003.01707.x · Cited by 76
The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma
Cadamuro, M., Stecca, T., Brivio, S., Mariotti, V., Fiorotto, R., Spirli, C., Strazzabosco, M., & Fabris, L. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.028 · Cited by 76
Recent advances in the morphological and functional heterogeneity of the biliary epithelium
Han, Y., Glaser, S., Meng, F., Francis, H., Marzioni, M., McDaniel, K., Alvaro, D., Venter, J., Carpino, G., Onori, P., et al. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213489926 · Cited by 75 · cited 1×
“Under physiological conditions, cholangiocytes stay quiescent, maintaining both local and systemic bile homeostasis (38, 96).”
BackgroundMahpour, A., & Mullen, A. C. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2020.100177 · Cited by 74
Rosenberg, N., Van Haele, M., Lanton, T., Brashi, N., Bromberg, Z., Adler, H., Giladi, H., Peled, A., Goldenberg, D. S., Axelrod, J. H., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.07.029 · Cited by 72
Tadlock, L., & Patel, T. (2001) · Hepatology · doi:10.1053/jhep.2001.20676 · Cited by 71
Zhou, Y., Song, S., Tian, M., Tang, Z., Wang, H., Fang, Y., Qu, W., Jiang, X., Tao, C.-Y., Huang, R., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003031 · Cited by 71
The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary Malignancies
Özdirik, B., Müller, T., Wree, A., Tacke, F., & Sigal, M. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136975 · Cited by 70 · cited 1×
“Notably, the microbiota has emerged as a crucial mediator of BEC functions (50).”
BackgroundSelf-citationThe Gut Microbiome and Ferroptosis in MAFLD
Ji, J., Wu, L., Wei, J., Wu, J., & Guo, C. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00136 · Cited by 69
Lakehal, F., Wendum, D., Barbu, V., Becquemont, L., Poupon, R., Balladur, P., Hannoun, L., Ballet, F., Beaune, P. H., & Housset, C. (1999) · Hepatology · doi:10.1002/hep.510300619 · Cited by 68 · cited 1×
“Interestingly, cholangiocytes are implicated in drug metabolism as they were shown to express cytochrome P450 (CYP450) superfamily members (69, 70) .”
BackgroundDrug and toxin-induced bile duct disorders
Geubel, A. P., & Sempoux, C. L. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.2369.x · Cited by 68 · cited 1×
“Additionally, fluorodeoxyuridines and 5-fluorouracil were revealed to selectively induce injuries in large bile ducts (68).”
BackgroundCholangiopathies – Towards a molecular understanding
Tam, P. K. H., Yiu, R. S. W., Lendahl, U., & Andersson, E. R. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.08.024 · Cited by 64
Hu, G., Gong, A.-Y., Liu, J., Zhou, R., Deng, C., & Chen, X.-M. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00490.2009 · Cited by 63
The Spectrum of Reactive Cholangiocytes in Primary Sclerosing Cholangitis
Guicciardi, M. E., Trussoni, C. E., LaRusso, N. F., & Gores, G. J. (2020) · Hepatology · doi:10.1002/hep.31067 · Cited by 62
Isse, K., Harada, K., & Nakanuma, Y. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01465.x · Cited by 61 · cited 1×
“IL-8 Human primary iBECs (from the non-neoplastic area of surgically resected livers of three patients with metastatic liver cancer) exposed to LPS and IL-1b and TNF-a (108) Liver samples from patients with chronic viral hepatitis/liver cirrhosis/sepsis/extrahepatic biliary obstruction/fulminant hepatitis/PBC/PSC”
BackgroundGovaere, O., Cockell, S., Van Haele, M., Wouters, J., Van Delm, W., Van den Eynde, K., Bianchi, A., van Eijsden, R., Van Steenbergen, W., Monbaliu, D., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5228 · Cited by 61
Maroni, L., Agostinelli, L., Saccomanno, S., Pinto, C., Giordano, D. M., Rychlicki, C., Minicis, S. D., Trozzi, L., Bañales, J. M., Melum, E., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.10.010 · Cited by 61 · cited 2×
“Upon sensing these stimuli, signaling cascades mainly involving NF-kB, mitogen-activated protein kinase (MAPK) and inflammasome, are rapidly activated (102, 111).”
BackgroundBile acids, FGF15/19 and liver regeneration: From mechanisms to clinical applications
Álvarez‐Sola, G., Uriarte, I., Latasa, M. U., Jiménez, M., Bárcena‐Varela, M., Santamaría, E., Urtasun, R., Rodríguez‐Ortigosa, C. M., Prìeto, J., Berraondo, P., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.06.025 · Cited by 59
Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium
Strazzabosco, M., Fiorotto, R., Cadamuro, M., Spirli, C., Mariotti, V., Kaffe, E., Scirpo, R., & Fabris, L. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.023 · Cited by 59
Alabraba, E. B., Lai, V., Boon, L., Wigmore, S. J., Adams, D. H., & Afford, S. C. (2008) · Hepatology · doi:10.1002/hep.22011 · Cited by 58 · cited 1×
“Moreover, LPS and IFN-activated liver-derived macrophages (LDM) express high level of CD154 (also known as CD40 ligand, CD40L), which triggers the CD40-dependent changes of secreting proinflammatory cytokines with increased IL-3, IL-12p70, IL-10 and GM-CSF but reduced CXCL10, IL-6 and CCL2 in human cholangiocytes (89).”
BackgroundBiology of Cholangiocytes: From Bench to Bedside
Yoo, K.-S., Lım, W., & Choi, H. S. (2016) · Gut and Liver · doi:10.5009/gnl16033 · Cited by 57
Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies
Giordano, D. M., Pinto, C., Maroni, L., Benedetti, A., & Marzioni, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103003 · Cited by 55 · cited 2×
“In terms of physiology, the gut barrier stands as the first line of defense preventing external insults from entering the organism via the venous system, while bile duct acts as the front-line defending bile-derived insults (12).”
BackgroundBiliary NIK promotes ductular reaction and liver injury and fibrosis in mice
Zhang, Z., Zhong, X., Shen, H., Sheng, L., Liangpunsakul, S., Lok, A. S., Omary, M. B., Wang, S., & Rui, L. (2022) · Nature Communications · doi:10.1038/s41467-022-32575-8 · Cited by 53 · cited 2×
“While the ablation of NIK significantly decreased the expression of Il-1b, Il-4, Il-6, iNos, Tnfa, Mcp1 and Tgfb1, thereby attenuating liver fibrosis (25).”
BackgroundAseem, S. O., Jalan-Sakrikar, N., Chi, C., Navarro-Corcuera, A., De Assuncao, T. M., Hamdan, F. H., Chowdhury, S., Banales, J. M., Johnsen, S. A., Shah, V. H., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.10.008 · Cited by 52
Bile acids and their receptors during liver regeneration: “Dangerous protectors”
Merlen, G., Bedoya, J. U., Bidault, V., Kahale, N., Glénisson, M., Doignon, I., Rainteau, D. P., & Tordjmann, T. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.03.002 · Cited by 51
Biliary epithelial trefoil peptide expression is increased in biliary diseases
Srivatsa, G., Giraud, A., Ulaganathan, M., Yeomans, N. D., Dow, C., & Nicoll, A. (2002) · Histopathology · doi:10.1046/j.1365-2559.2002.01347.x · Cited by 50
Regulation of EGFR signalling by palmitoylation and its role in tumorigenesis
Kadry, Y. A., Lee, J.-Y. L., & Witze, E. S. (2021) · Open Biology · doi:10.1098/rsob.210033 · Cited by 49
Cholangiocyte Injury and Ductopenic Syndromes
Xia, X., DeMorrow, S., Francis, H., Glaser, S. S., Alpini, G. D., Marzioni, M., Fava, G., & LeSage, G. (2007) · Seminars in Liver Disease · doi:10.1055/s-2007-991516 · Cited by 47 · cited 1×
“Drug-induced cholangiopathies [also known as drug-induced vanishing bile duct syndrome (VBDS)] were first described in rare clinical cases (66).”
BackgroundElevated interleukin‐8 in bile of patients with primary sclerosing cholangitis
Zweers, S. J., Shiryaev, A., Komuta, M., Vesterhus, M., Hov, J. R., Perugorria, M. J., de Waart, D. R., Chang, J., Tol, S., te Velde, A. A., et al. (2016) · Liver International · doi:10.1111/liv.13092 · Cited by 47 · cited 3×
“Likewise, IL-8 secreted by the activated cholangiocytes can stimulate the production of profibrotic genes, suggesting that IL-8 may be involved in the pathogenesis of cholangiopathies (28).”
BackgroundResultKennedy, L., Francis, H., Invernizzi, P., Venter, J., Wu, N., Carbone, M., Eric Gershwin, M., Bernuzzi, F., Franchitto, A., Alvaro, D., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802606r · Cited by 47
Lactoferrin and lysozyme in the intrahepatic bile duct of normal livers and hepatolithiasis
Saito, K., & Nakanuma, Y. (1992) · Journal of Hepatology · doi:10.1016/0168-8278(92)90028-n · Cited by 46
Guillot, A., Kohlhepp, M., Bruneau, A., Heymann, F., & Tacke, F. (2020) · Cancers · doi:10.3390/cancers12092449 · Cited by 46
Self-citationThe Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis
Barron‐Millar, B., Ogle, L., Mells, G., Flack, S., Badrock, J., Sandford, R., Kirby, J., Palmer, J., Jopson, L., Brain, J., et al. (2021) · Hepatology · doi:10.1002/hep.32011 · Cited by 45
Nishikawa, H., Enomoto, H., Iwata, Y., Hasegawa, K., Nakano, C., Takata, R., Nishimura, T., Yoh, K., Aizawa, N., Sakai, Y., et al. (2016) · Hepatology Research · doi:10.1111/hepr.12595 · Cited by 45
Inoue, K., Torimura, T., Nakamura, T., Iwamoto, H., Masuda, H., Abe, M., Hashimoto, O., Koga, H., Ueno, T., Yano, H., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2041 · Cited by 45
Jusakul, A., Loilome, W., Namwat, N., Haigh, W. G., Kuver, R., Dechakhamphu, S., Sukontawarin, P., Pinlaor, S., Lee, S. P., & Yongvanit, P. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.10.009 · Cited by 44
Trussoni, C. E., O’Hara, S. P., & LaRusso, N. F. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00909-9 · Cited by 43
Yao, X., Wang, Zhou, Wang, Dai, Zhang, & Yan, Y. (2012) · OncoTargets and Therapy · doi:10.2147/ott.s36213 · Cited by 42
Elferink, R. P. J. O. (2003) · Gut · doi:10.1136/gut.52.suppl_2.ii42 · Cited by 41
Techasen, A., Namwat, N., Loilome, W., Duangkumpha, K., Puapairoj, A., Saya, H., & Yongvanit, P. (2014) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.125 · Cited by 40
Gut–Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology
Maroni, L., Ninfole, E., Pinto, C., Benedetti, A., & Marzioni, M. (2020) · Cells · doi:10.3390/cells9030736 · Cited by 40
Al Suraih, M. S., Trussoni, C. E., Splinter, P. L., LaRusso, N. F., & O’Hara, S. P. (2020) · Liver International · doi:10.1111/liv.14569 · Cited by 40
Identification of a TGF-β/SMAD/lnc-UTGF positive feedback loop and its role in hepatoma metastasis
Wu, M., Yuan, Y., Huang, B.-Y., Chen, J.-X., Li, B., Fang, J., & Zhuang, S. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00781-3 · Cited by 40
Guillot, A., Gasmi, I., Brouillet, A., Ait‐Ahmed, Y., Calderaro, J., Ruiz, I., Gao, B., Lotersztajn, S., Pawlotsky, J., & Lafdil, F. (2018) · Hepatology Communications · doi:10.1002/hep4.1145 · Cited by 38
Self-citationBiliary Epithelial Senescence in Liver Disease: There Will Be SASP
Meadows, V., Baiocchi, L., Kundu, D., Sato, K., Fuentes, Y., Wu, C., Chakraborty, S., Glaser, S. S., Alpini, G. D., Kennedy, L. L., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.803098 · Cited by 38
Cellular Senescence in Hepatocellular Carcinoma: The Passenger or the Driver?
Cai, X., Guillot, A., & Liu, H. (2022) · Cells · doi:10.3390/cells12010132 · Cited by 38
Self-citationZhang, D., Li, H., Jiang, X., Cao, L., Wen, Z., Yang, X., & Xue, P. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0528-6 · Cited by 38
Ductular reaction promotes intrahepatic angiogenesis through Slit2–Roundabout 1 signaling
Coll, M., Ariño, S., Martínez‐Sánchez, C., Garcia‐Pras, E., Gallego, J., Moles, A., Aguilar‐Bravo, B., Blaya, D., Vallverdú, J., Rubio‐Tomás, T., et al. (2022) · Hepatology · doi:10.1002/hep.32140 · Cited by 38
Alsuraih, M., O’Hara, S. P., Woodrum, J. E., Pirius, N. E., & LaRusso, N. F. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100250 · Cited by 37
Wu, C.-T., Davis, P. A., Luketic, V. A., & Gershwin, M. E. (2004) · Journal of Immunology Research · doi:10.1080/17402520400004177 · Cited by 36
Mancinelli, R., Onori, P., Gaudio, E., Franchitto, A., Carpino, G., Ueno, Y., Alvaro, D., Annarale, L. P., DeMorrow, S., & Francis, H. (2009) · Experimental Biology and Medicine · doi:10.3181/0808-rm-255 · Cited by 35
Harada, K., Shimoda, S., Ikeda, H., Chiba, M., Hsu, M., Sato, Y., Kobayashi, M., Ren, X. S., Ohta, H., Kasashima, S., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2010.02367.x · Cited by 35 · cited 15×
“Senescent cholangiocytes can be found in mouse PBC samples at the early disease stage, resulting from the over-activation of the Sct/SR pathway and its induced TGF-b1 secretion, which triggered cytokine-induced senescence in an autocrine manner.”
BackgroundInfluentialPathological features of primary sclerosing cholangitis identified by bile proteomic analysis
Rupp, C., Bode, K. A., Leopold, Y., Sauer, P., & Gotthardt, D. N. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.09.012 · Cited by 35 · cited 1×
“Cholangiocytes detect pathogens via the TLRs and then secrete antimicrobial IgA into the bile, which serves a vital barrier against germs from both the duodenum and portal vein (100, 101), as well as a variety of cytokines (IL-6 and MCP-1) (102), chemokines (103) and other active anti-microbial peptides (e.”
BackgroundPuthdee, N., Sriswasdi, S., Pisitkun, T., Ratanasirintrawoot, S., Israsena, N., & Tangkijvanich, P. (2021) · Cancer Gene Therapy · doi:10.1038/s41417-021-00387-5 · Cited by 35
The role of the liver in Translocation of IgA into the Gastrointestinal Tract
Brown, W. R., & Kloppel, T. Μ. (1989) · Immunological Investigations · doi:10.3109/08820138909112242 · Cited by 34 · cited 2×
“Hepatocytes effectively secrete most of the IgA in rodents, whereas cholangiocytes represent the main source of IgA secretion in human liver (101).”
BackgroundThe role of cholangiocytes in the development of chronic inflammatory liver disease
Afford, S. C. (2002) · Frontiers in Bioscience · doi:10.2741/a923 · Cited by 34 · cited 1×
“For instance, IL-1 and tumor necrosis factor-a (TNF-a) trigger cholangiocytes to release epithelial cell-derived neutrophil-activating protein (ENA-78) and growth-related gene products (72).”
BackgroundA Step Further in the Analysis of Human Bile Proteome
Farina, A., Dumonceau, J., Delhaye, M., Frossard, J., Hadengue, A., Hochstrasser, D. F., & Lescuyer, P. (2011) · Journal of Proteome Research · doi:10.1021/pr200011b · Cited by 31
Hay, A. J., & Zhu, J. (2016) · Advances in applied microbiology · doi:10.1016/bs.aambs.2016.07.019 · Cited by 31
Cited by
(2025) · doi:10.1038/s41423-025-01313-7 · Cited by 97
“In reference to “ cholangio-kines ” , the BEC secretome is versatile, and we have just started to explore its potential for shaping portal in fl ammation [156].”
Self-citationCentral role for cholangiocyte pathobiology in cholestatic liver diseases
Jalan-Sakrikar, N., Guicciardi, M. E., O’Hara, S. P., Azad, A., LaRusso, N. F., Gores, G. J., & Huebert, R. C. (2025) · Hepatology · doi:10.1097/hep.0000000000001093 · Cited by 38
The impact of aging on liver health and the development of liver diseases
Williams, S. N., & Ding, W. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000808 · Cited by 35
“[29] As the name implies, LSECs are specialized cells that line the hepatic sinusoids and are fenestrated to allow for blood filtration.”
Xiao, M.-H., Wu, S., Liang, P., Ma, D., Zhang, J., Chen, H., Zhong, Z., Liu, J., Jiang, H., Feng, X., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105138 · Cited by 28
Microenvironmental control of the ductular reaction: balancing repair and disease progression
Sorrentino, G. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07590-4 · Cited by 28
“Cholangio-kines secretion is in fl uenced by different factors such as tissue in fl ammation, infection, and metabolic dysregulation and actively maintain the portal area ’ s microenvironment contributing to immune response and in fl ammation [81].”
Metadata
- Authors
- Cai, X., Tacke, F., Guillot, A., & Liu, H.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- Stiftung Charité (DE)
- Changzhou No.2 People's Hospital (CN)
- Corresponding author
- Guillot, Adrien
- Liu, Hanyang
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2023-05-16
- Volume
- 14
- Pages
- 1192840-1192840
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC10229055
- OpenAlex
- W4376954999
- Cited by
- 40
- References
- 229
- Citations by year
- 2026: 9 · 2025: 21 · 2024: 8 · 2023: 2
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Deutsche Forschungsgemeinschaft (DFG SFB/TRR 296, CRC1382, 403224013)
- Deutsche Gesellschaft für Erziehungswissenschaft (BMBF DEEP-HCC consortium)
- Changzhou Science and Technology Bureau (CJ20220142)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
- Keywords
- cholangiocytes, cytokines, bile duct injury, liver fibrosis, ductular reaction, liver regeneration, liver inflammation, hepatocarcinogenesis, cellular senescence, biliary tract
- MeSH terms
- Bile Ducts, Epithelial Cells, Fibrosis, Humans, Inflammation, Liver
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.